New scope aims to bust kidney stones in one go
NCT ID NCT07071948
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a new device called VISOR for removing kidney stones. It combines stone breaking, suction, and pressure control in one tool. About 20 adults with 1-3 cm stones will undergo surgery with VISOR. The goal is to see if it clears stones safely and effectively, with a CT scan within 24 hours and a follow-up at one month.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multifunctional Integrated Flexible Ureteroscope (VISOR)
What this could lead to
If successful, this device could make kidney stone surgery safer and more effective, reducing the need for repeat procedures.
What could go wrong
This is a small, early-stage trial with only 20 participants. The device may not work as well in larger groups, and there are risks like infection or injury during surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, Zhejiang, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••